New drug awaiting FDA approval may reverse bone loss.
D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational